<DOC>
	<DOC>NCT00527046</DOC>
	<brief_summary>A 24-month, placebo controlled, double dummy, parallel-design outpatient trial in generally healthy elderly men and women who are at risk of becoming frail.</brief_summary>
	<brief_title>Effects Of An Oral Growth Hormone Secretagogue In Older Functionally Limited Adults</brief_title>
	<detailed_description />
	<criteria>6584 years old, BMI &lt; 30, at risk for functional decline based on SF36, Instrumental Activities of Daily Living (per Nagy's), or 2 or more falls in prior 2 years Significant history or symptoms of acute medical conditions, currently in an exercise program, pain or other conditions that would prevent participating in exercise testing</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>